Psilocybin and music study for healthy volunteers
Treatments studied
Part of Mental health clinical trials.
This study tests how music affects your experience with psilocybin, a psychedelic substance. It may help researchers understand how to create the best setting for psilocybin therapy.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be fluent in English and have no hearing problems.
- You must be right-handed and weigh at least 88 pounds (40 kg) with a BMI of 16 or higher.
- You must be generally healthy and pass medical checks including blood and heart tests.
- You must have little to no past use of hallucinogens (like LSD or magic mushrooms), preferably none in the last 5 years and fewer than 10 times total.
- You must agree to avoid certain medications, supplements, and recreational drugs around the study sessions.
- You must have proof of COVID-19 vaccination.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study gives a single dose of psilocybin to healthy adults who are curious about psychedelics but have little to no past use. Researchers will measure how it affects your mood, brain activity, and body chemistry to understand its effects better.
This Phase 1/2 study tests psilocybin to see how it affects brain signals and the “content” of thoughts while you are monitored during the study. Because participants must be generally healthy and mentally stable, it may be an option if you meet those safety and medication rules and are comfortable having your brain activity measured.
This early-stage research study tests how psilocybin (a naturally occurring compound from certain mushrooms) works when combined with a medication that blocks a specific serotonin pathway in the brain. Researchers want to understand how these two substances interact in healthy volunteers to inform future psychiatric treatment studies.
This study tests how certain psychoactive substances affect your mind and body. It is looking for healthy volunteers to take part in supervised sessions to explore the effects of these drugs.
This trial tests whether taking pimavanserin before psilocybin changes the drug's effects in healthy volunteers who have never used psychedelics. It aims to understand how to make psychedelic therapy safer and more predictable.
This study tests whether a meditation-based music program or a music-only program helps people prepare for a psychedelic experience. It's looking for people who have used psychedelics very little before and have no major health issues.
Hear when a new Psilocybin trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.